Clinical Trials Insight: 700037565
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 05 Oct 2013
At a glance
- Drugs Glatiramer acetate (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Teva Pharmaceutical Industries
- 26 Feb 2010 15-year results were published in Multiple Sclerosis, according to a Teva Pharmaceuticals media release.
- 12 Sep 2009 Interim results preseneted at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
- 11 Sep 2009 Teva Pharmaceuticals report that results will be presented at ECTRIMS 2009.